Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
158.70
-0.60 (-0.38%)
Apr 1, 2025, 5:24 PM IDT
Novolog (Pharm-Up 1966) Revenue
In the year 2024, Novolog (Pharm-Up 1966) had annual revenue of 2.02B ILS with 23.01% growth. Novolog (Pharm-Up 1966) had revenue of 689.88M in the quarter ending December 31, 2024, with 74.01% growth.
Revenue
2.02B
Revenue Growth
+23.01%
P/S Ratio
0.40
Revenue / Employee
2.12M
Employees
955
Market Cap
813.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.02B | 378.11M | 23.01% |
Dec 31, 2023 | 1.64B | 135.54M | 8.99% |
Dec 31, 2022 | 1.51B | 252.70M | 20.13% |
Dec 31, 2021 | 1.26B | 121.61M | 10.73% |
Dec 31, 2020 | 1.13B | 129.51M | 12.90% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 60.26B |
Danel (Adir Yeoshua) | 2.77B |
Kamada | 586.24M |
Bait Bakfar | 103.40M |
Ilex Medical | 982.96M |
BrainsWay | 149.39M |
SofWave Medical | 217.27M |
Golden House | 47.96M |